BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24449617)

  • 21. Peptide-Based Fluorescent Probes for Deacetylase and Decrotonylase Activity: Toward a General Platform for Real-Time Detection of Lysine Deacylation.
    Rooker DR; Klyubka Y; Gautam R; Tomat E; Buccella D
    Chembiochem; 2018 Mar; 19(5):496-504. PubMed ID: 29235227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors.
    Reddy DN; Ballante F; Chuang T; Pirolli A; Marrocco B; Marshall GR
    J Med Chem; 2016 Feb; 59(4):1613-33. PubMed ID: 26681404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innovative Strategies for Selective Inhibition of Histone Deacetylases.
    Maolanon AR; Madsen AS; Olsen CA
    Cell Chem Biol; 2016 Jul; 23(7):759-768. PubMed ID: 27447046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins).
    Huber K; Schemies J; Uciechowska U; Wagner JM; Rumpf T; Lewrick F; Süss R; Sippl W; Jung M; Bracher F
    J Med Chem; 2010 Feb; 53(3):1383-6. PubMed ID: 20030343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysine Deacetylase Substrate Selectivity: A Dynamic Ionic Interaction Specific to KDAC8.
    Toro TB; Swanier JS; Bezue JA; Broussard CG; Watt TJ
    Biochemistry; 2021 Aug; 60(33):2524-2536. PubMed ID: 34357750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Lysine Deacetylases (KDACs) in Parasites.
    Wang Q; Rosa BA; Nare B; Powell K; Valente S; Rotili D; Mai A; Marshall GR; Mitreva M
    PLoS Negl Trop Dis; 2015; 9(9):e0004026. PubMed ID: 26402733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone Deacetylase 11 Is an ε-N-Myristoyllysine Hydrolase.
    Moreno-Yruela C; Galleano I; Madsen AS; Olsen CA
    Cell Chem Biol; 2018 Jul; 25(7):849-856.e8. PubMed ID: 29731425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.
    Seok YM; Lee HA; Park KM; Hwangbo MH; Kim IK
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):799-808. PubMed ID: 27106211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Current State of NAD
    Schiedel M; Robaa D; Rumpf T; Sippl W; Jung M
    Med Res Rev; 2018 Jan; 38(1):147-200. PubMed ID: 28094444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous Histone Deacylase Activity Assays.
    Zessin M; Meleshin M; Sippl W; Schutkowski M
    Methods Mol Biol; 2023; 2589():411-428. PubMed ID: 36255640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylation of Sirt2 by p300 attenuates its deacetylase activity.
    Han Y; Jin YH; Kim YJ; Kang BY; Choi HJ; Kim DW; Yeo CY; Lee KY
    Biochem Biophys Res Commun; 2008 Oct; 375(4):576-80. PubMed ID: 18722353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticancer agents targeted to sirtuins.
    Kozako T; Suzuki T; Yoshimitsu M; Arima N; Honda S; Soeda S
    Molecules; 2014 Dec; 19(12):20295-313. PubMed ID: 25486244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysine Deacetylases Exhibit Distinct Changes in Activity Profiles Due to Fluorophore Conjugation of Substrates.
    Toro TB; Bryant JR; Watt TJ
    Biochemistry; 2017 Aug; 56(34):4549-4558. PubMed ID: 28749131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification of metal-dependent lysine deacetylases with consistently high activity.
    Toro TB; Painter RG; Haynes RA; Glotser EY; Bratton MR; Bryant JR; Nichols KA; Matthew-Onabanjo AN; Matthew AN; Bratcher DR; Perry CD; Watt TJ
    Protein Expr Purif; 2018 Jan; 141():1-6. PubMed ID: 28843507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cysteine derivatives as acetyl lysine mimics to inhibit zinc-dependent histone deacetylases for treating cancer.
    Wang J; Cao Z; Wang F; Wang P; An J; Fu X; Liu T; Li Y; Li Y; Zhao Y; Lin H; He B
    Eur J Med Chem; 2021 Dec; 225():113799. PubMed ID: 34500130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiological and pathophysiological functions of SIRT1.
    Wojcik M; Mac-Marcjanek K; Wozniak LA
    Mini Rev Med Chem; 2009 Mar; 9(3):386-94. PubMed ID: 19275731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assays to Study Enzymatic and Non-Enzymatic Protein Lysine Acetylation In Vitro.
    Graf LG; Vogt R; Blasl AT; Qin C; Schulze S; Zühlke D; Sievers S; Lammers M
    Curr Protoc; 2021 Nov; 1(11):e277. PubMed ID: 34748287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of NAD+ dependent histone deacetylases (sirtuins) in ageing.
    Trapp J; Jung M
    Curr Drug Targets; 2006 Nov; 7(11):1553-60. PubMed ID: 17100594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications.
    Wang Z; Zhao YT; Zhao TC
    Exp Biol Med (Maywood); 2021 Jan; 246(2):213-225. PubMed ID: 32727215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly Sensitive Lysine Deacetylase Assay Based on Acetylated Firefly Luciferase.
    Spinck M; Ecke M; Sievers S; Neumann H
    Biochemistry; 2018 Jul; 57(26):3552-3555. PubMed ID: 29851343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.